S100A9 is a novel biomarker for poor survival of breast cancer patients

被引:0
|
作者
Noetzel, Erik
Schutz, Anke
Bernhagen, Jurgen
Hartmann, Arndt
Dahl, Edgar
Knuchel-Clarke, Ruth
机构
关键词
D O I
10.1158/1538-7445.AM10-LB-218
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
LB-218
引用
收藏
页数:4
相关论文
共 50 条
  • [21] ID1 Promotes Breast Cancer Metastasis by S100A9 Regulation
    Gumireddy, Kiranmai
    Li, Anping
    Kossenkov, Andrew V.
    Cai, Kathy Q.
    Liu, Qin
    Yan, Jinchun
    Xu, Hua
    Showe, Louise
    Zhang, Lin
    Huang, Qihong
    MOLECULAR CANCER RESEARCH, 2014, 12 (09) : 1334 - 1343
  • [22] High Transcription Levels Of S100A8 and S100A9 In Acute Myeloid Leukemia Are Predictors For Poor Overall Survival
    Hu, Shao-yan
    Zhanel, Ming-ying
    Wu, Shui-yan
    Wu, Dong
    Ashwani, Neetika
    Pan, Jian
    He, Hai-long
    Cen, Jian-nong
    Chen, Zi-Xing
    Chen, Chien-Shing
    BLOOD, 2013, 122 (21)
  • [23] S100A9 serum levels are associated with survival prognosis in patients with brain metastases
    Steindl, A.
    Kienzle, A.
    Tomasich, E.
    Berger, J. M.
    Englisch, C.
    Gottmann, L.
    Korpan, M.
    Kleinberger, M.
    Starzer, A. M.
    Kiesel, B.
    Widhalm, G.
    Eckert, F.
    Preusser, M.
    Berghoff, A. S.
    ANNALS OF ONCOLOGY, 2023, 34 : S405 - S405
  • [24] Serum S100A8/S100A9 levels are associated with increased risk of brain metastasis in patients with aggressive breast cancer
    Villodre, Emilly S.
    Hu, Xiaoding
    Song, Juhee
    Gomez, Kristen
    Su, Xiaoping
    Reuben, James
    Ueno, Naoto T.
    Tripathy, Debu
    Krishnamurthy, Savitri
    Debeb, Bisrat
    CANCER RESEARCH, 2023, 83 (05)
  • [25] The calcium binding proteins S100A8 and S100A9 as novel markers for human prostate cancer
    Hermani, Alexander
    Grobholz, Rainer
    Trojan, Lutz
    Angel, Peter
    Mayer, Doris
    EJC SUPPLEMENTS, 2006, 4 (06): : 40 - 40
  • [26] The damage-associated molecular pattern S100A8/S100A9 as a potential biomarker in patients with active myocarditis
    Mueller, I. Irene
    Kuehl, U.
    Vogl, T.
    Pieske, B.
    Van Linthout, S.
    Tschoepe, C.
    EUROPEAN JOURNAL OF HEART FAILURE, 2018, 20 : 166 - 166
  • [27] Review of S100A9 biology and its role in cancer
    Markowitz, Joseph
    Carson, William E., III
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2013, 1835 (01): : 100 - 109
  • [28] Emerging targets for cancer treatment: S100A9/RAGE
    Valiente, M.
    Sepulveda, J. M.
    Perez, A.
    ESMO OPEN, 2023, 8 (01)
  • [29] S100A9 as a Pharmacological Target Molecule in Inflammation and Cancer
    Leanderson, Tomas
    Liberg, David
    Ivars, Fredrik
    ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS, 2015, 15 (02) : 97 - 104
  • [30] From bench to bedside: Calprotectin (S100A8/S100A9) as a biomarker in rheumatoid arthritis
    Inciarte-Mundo, Jose
    Frade-Sosa, Beatriz
    Sanmarti, Raimon
    FRONTIERS IN IMMUNOLOGY, 2022, 13